INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOFACITINIB

被引：4

作者：

Bejarano, Marisel ^{[1
]}

Natalia Tamborenea, Maria ^{[2
]}

Alberto Goni, Mario ^{[3
]}

Saldarriaga, Lina ^{[4
]}

Pisoni, Cecilia ^{[5
]}

Garcia Salinas, Rodrigo ^{[6
]}

Salcedo, Mariana ^{[7
]}

Helling, Claudia ^{[8
]}

Salas, Adrian ^{[8
]}

机构：

[1] Hosp Gen Agudos Bernardino Rivadavia, Rheumatol Unit, Buenos Aires, DF, Argentina

[2] Hosp Gen Agudos Bernardino Rivadavia, Buenos Aires, DF, Argentina

[3] Inst Lucha Antipoliomielit & Rehabil Lisiado, Rosario, Santa Fe, Argentina

[4] Hosp Univ San Jorge, Pereira, Colombia

[5] CEMIC, Buenos Aires, DF, Argentina

[6] Hosp Italiano La Plata, La Plata, Buenos Aires, Argentina

[7] Inst Invest Clin Zarate, Zarate, Argentina

[8] Pfizer SRL, Buenos Aires, DF, Argentina

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷

关键词：

D O I：

10.1136/annrheumdis-2019-eular.8014

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0418

引用

页码：1672 / 1672

页数：1

共 50 条

[41] MORTALITY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INTERSTITIAL LUNG DISEASE TREATED WITH TUMOUR NECROSIS FACTOR INHIBITOR OR RITUXIMAB
Druce, Katie L.
Iqbal, Kundan
Watson, Kath
Symmons, Deborah P. M.
Hyrich, Kimme L.
Kelly, Clive
RHEUMATOLOGY, 2017, 56 : 127 - 128
[42] DISEASE ACTIVITY AND DEATH IN PATIENTS WITH RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE
Kelly, C.
Young, A.
Koduri, G.
Arthanari, S.
Nisar, M.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 409 - 409
[43] DISEASE ACTIVITY IN ESCALATION OR DE-ESCALATION OF DOSAGE OF TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS - THE FIRST RESULTS OF RUSSIAN NATIONAL REGISTER OF PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOFACITINIB
Gaydukova, Inna
Mazurov, V.
Vasilenko, Elizaveta
Zhilyaev, Evgeniy
Poncratov, Vyacheslav
Sorotskaya, Valentina
Lukina, Galina
Fomina, Oxana
Babaeva, Aida
Lapkina, N.
Misiyuk, Anna
Pavlova, A.
Nasonov, Evgeny
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 746 - 746
[44] Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
Spinelli, Francesca Romana
Garufi, Cristina
Mancuso, Silvia
Ceccarelli, Fulvia
Truglia, Simona
Conti, Fabrizio
SCIENTIFIC REPORTS, 2023, 13 (01):
[45] Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib
Francesca Romana Spinelli
Cristina Garufi
Silvia Mancuso
Fulvia Ceccarelli
Simona Truglia
Fabrizio Conti
Scientific Reports, 13 (1)
[46] CYTOKINE ANALYSIS IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH RHEUMATOID ARTHRITIS
Lisbona, J. M.
Mucientes, A.
Oliver-Martos, B.
Diaz-Cordobes, G.
Urena, I.
Redondo, R.
Manrique Arija, S.
Fernandez-Nebro, A.
Mena-Vazquez, N.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 848 - 848
[47] Eternacept for the treatment of patients with rheumatoid arthritis and concurrent interstitial lung disease
Horai, Y.
Miyamura, T.
Shimada, K.
Takahama, S.
Minami, R.
Yamamoto, M.
Suematsu, E.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (01) : 117 - 121
[48] CYCLOPHOSPHAMIDE IN THE TREATMENT OF SEVERE INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Karjigi, Uma
Gordon, Judith
Palmer, Evelyn
Middleton, David
Nisar, Mohammed
Young, Adam
Dawson, Julie
Arthanari, Subha
Woodhead, Felix
Forbes-Price, Alex
Sathi, Nav
Ahmed, Yasmeen
Koduri, Gouri
Kelly, Clive
RHEUMATOLOGY, 2015, 54 : 77 - 77
[49] Interstitial lung disease in rheumatoid arthritis patients receiving leflunomide.
Cannon, GW
Strand, V
Simon, LS
Kavanaug, AF
Hochberg, MC
Scarazzini, L
Holden, WL
ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S561 - S561
[50] Clinical Characterization of Extensive Interstitial Lung Disease in Rheumatoid Arthritis Patients
Yamasaki, Masaomi
Haga, Yoshiteru
Inoue, Makoto
Tonooka, Kumiko
Katsuyama, Naooki
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S825 - S826

← 1 2 3 4 5 →